摘要
目的研究表没食子儿茶素(epigallocatechin,EGC)对Aβ25-35损伤SH-SY5Y细胞的保护作用及机制。方法采用Aβ25-35损伤SH-SY5Y细胞,MTT和LDH法,考察EGC对SH-SY5Y细胞活力的影响。应用DCFH-DA荧光探针检测细胞内ROS水平,通过测定细胞内SOD、GSH-Px和MDA活性,考察细胞氧化应激水平。Westernblot测定细胞中Nrf2、NQO1、HO-1、Prdx6和Trx1蛋白含量。结果Aβ25-35损伤SH-SY5Y细胞,导致细胞存活率明显降低。5、10、20μmol·L^-1EGC能够减轻Aβ25-35诱导的SH-SY5Y细胞损伤及LDH释放。而且EGC能够减少Aβ25-35诱导的细胞内ROS水平的增加,减轻氧化应激损伤。同时,EGC能够明显增强Aβ25-35损伤后Nrf2、NQO1、HO-1、Prdx6和Trx1的表达。结论EGC能够抑制Aβ25-35诱导的SH-SY5Y细胞损伤,通过促进Nrf2核转位,提高抗氧化水平,降低Aβ25-35神经毒性。
Aim To investigate the protective effect of epigallocatechin(EGC) on SH-SY5Y cells induced by Aβ25-35 injury.Methods MTT and LDH assay were employed to investigate the effects of EGC on viability of SH-SY5Y cells.DCFH-DA fluorescent probe was used to detect the intracellular ROS levels,and the activity of SOD,GSH-Px and MDA in cells was measured to investigate the level of oxidative stress in cells.Western blot analysis was used to determine Nrf2,NQO1,HO-1,Prdx6 and Trx1 levels in cells.Results SH-SY5Y cells were injured by Aβ25-35 treatment,and the cell viability was significantly reduced.5,10 and 20 μmol·L -1 of EGC alleviated Aβ25-35 induced SH-SY5Y cell injury and reduced LDH release.In addition,EGC could reduce the intracellular ROS level induced by Aβ25-35 and inhibit oxidative stress.At the same time,EGC could significantly enhance the expression of Nrf2,NQO1,HO-1,Prdx6 and Trx1 after Aβ25-35 injury.Conclusions EGC could inhibit Aβ25-35-induced SH-SY5Y cell injury,increase the cells antioxidant levels and reduce the neurotoxicity of Aβ25-35 by promoting nuclear translocation of Nrf2.
作者
张雯
宋俊科
朱晓瑜
杨海光
王海港
许启泰
杜冠华
ZHANG Wen;SONG Jun-ke;ZHU Xiao-yu;Yang Hai-guang;WANG Hai-gang;XU Qi-tai;DU Guan-hua(State Key Lab of Bioactive Substances and Functions of Natural Medicines,Beijing Key Lab of Drug Target and Screening Research,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Hainan Green Areca Technology Development Co.LTD,Dingan Hainan 571200,China)
出处
《中国药理学通报》
CAS
CSCD
北大核心
2019年第10期1393-1398,共6页
Chinese Pharmacological Bulletin
基金
海南省重大科技计划资助项目(No ZDKJ2016003)
中国医学科学院医学与健康科技创新工程资助项目(No 2017-I2M-1-010)